Evolus rises after posting quarterly profit versus year-ago loss

Evolus

04/03/2025 22:07

** Shares of cosmetic drugmaker Evolus EOLS.O rise 3.7% to $14.88 in extended trade

** Co reports adjusted income of $6.7 million in Q4, compared with a year-ago loss of $3.7 million

** EOLS sees 2025 rev between $345 million and $355 million, versus Wall Street estimates of $351.3 million — LSEG

** Co says annual net revenue can reach at least $700 million by 2028

** EOLS rose 4.8% in 2024

 (Reporting by Puyaan Singh)

 ((Puyaan.Singh@thomsonreuters.com))